Richard S Finn1. Show Affiliations » 1. Hematology/Oncology, Geffen School of Medicine at University of California Los Angeles Los Angeles, CA 90095, USA. rfinn@mednet.ucla.edu
Abstract
Entities: Chemical
Mesh: See more » AgedBenzenesulfonates/adverse effectsBenzenesulfonates/therapeutic useCarcinoma, Hepatocellular/drug therapyCarcinoma, Hepatocellular/etiologyHepatitis B/complicationsHepatitis C/complicationsHumansLiver Neoplasms/drug therapyLiver Neoplasms/etiologyMaleNiacinamide/analogs & derivativesPhenylurea CompoundsProtein Kinase Inhibitors/adverse effectsProtein Kinase Inhibitors/therapeutic usePyridines/adverse effectsPyridines/therapeutic useRisk FactorsSorafenib
Substances: See more » BenzenesulfonatesPhenylurea CompoundsProtein Kinase InhibitorsPyridinesNiacinamideSorafenib
Year: 2010 PMID: 20432260 DOI: 10.1002/hep.23676
Source DB: PubMed Journal: Hepatology ISSN: 0270-9139 Impact factor: 17.425